Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT06065657

Effect of Nutritional Ketosis on Alcohol Metabolism

Status
Active Not Recruiting
Phase
Phase 2 / Phase 3
Study type
Interventional
Enrollment
23 (actual)
Sponsor
University of Pennsylvania · Academic / Other
Sex
All
Age
21 Years – 50 Years
Healthy volunteers
Accepted

Summary

The research study is being conducted in health controls to better understand the effects of ketosis on brain functioning after 3 different, randomly assigned, 3-day dietary interventions and the acute effects of alcohol after consuming about 4-5 alcohol beverages. The labs visits will use magnetic resonance imaging (MRI) scans to study the brain, measuring levels of nicotinamide adenine dinucleotide (NAD), lactate, neurotransmitters glutamate, and Gamma-aminobutyric acid (GABA).

Detailed description

The research study is being conducted to better understand the effects of ketosis on brain functioning and the acute effects of alcohol. Healthy participants will undergo three randomly assigned dietary interventions, each lasting three days, followed by a study lab visit day on day 4. The three interventions are: (1) Eat a ketogenic diet for 3 days, (2) eat a control diet for 3 days with a ketone supplement drink, and (3) eat a control diet for 3 days. The dietary interventions will be spaced 1 week apart. The ketone supplement drink "bis-octanoyl (R)-1,3-butanediol" (Kenetik: Ketone Drink, VitaNav Inc., Washington D.C.) 12.5g of ketones, TID PO (by mouth).) is a dietary supplement that has been extensively studied in humans and is designated by the FDA as Generally Recognized as Safe (GRAS). Its use in this study is experimental. On the day of the 3 labs visits days, magnetic resonance imaging (MRI) will be used to study the brain. Specifically, levels of nicotinamide adenine dinucleotide (NAD) (a coenzyme that is important for energy metabolism), lactate (a metabolite produced during energy metabolism), and neurotransmitters glutamate and GABA. Following the scans, participants will be provided a dose of alcohol that will elevate participants breath alcohol levels to approximately 0.08% to measure the acute effects of alcohol.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTKetone SupplementKetone supplement 3x day with control diet for 3 days.
OTHERControl DietControl Diet breakfast, lunch, and dinner for 3 days.
OTHERKetogenic dietKetogenic Diet breakfast, lunch, and dinner for 3 days.
DRUGEthanolAfter 3 days of diet intervention, participants will receive alcohol drinks that dose-adjusts for body weight and sex differences in pharmacokinetics and calculated to obtain a final breath alcohol concentration of 0.08%

Timeline

Start date
2024-02-29
Primary completion
2025-12-01
Completion
2026-12-01
First posted
2023-10-04
Last updated
2026-04-07

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT06065657. Inclusion in this directory is not an endorsement.